↓ Skip to main content

Acrofacial vitiligo secondary to PI3KCA inhibitor, alpelisib: case report

Overview of attention for article published in Frontiers in oncology, October 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
1 Dimensions